Weight gain and comorbidities associated with oral second-generation antipsychotics: analysis of real-world data for patients with schizophrenia or bipolar I disorder

BACKGROUND: Many second-generation antipsychotics (SGAs) are associated with weight gain and cardiometabolic effects. Antipsychotic-associated weight gain is linked to treatment interruptions, potentially increasing risk of relapse and hospitalization. This retrospective study assessed clinically si...

Descripción completa

Detalles Bibliográficos
Autores principales: Doane, Michael J., Bessonova, Leona, Friedler, Haley S., Mortimer, Kathleen M., Cheng, Harry, Brecht, Thomas, O’Sullivan, Amy K., Cummings, Hannah, McDonnell, David, Meyer, Jonathan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842889/
https://www.ncbi.nlm.nih.gov/pubmed/35164737
http://dx.doi.org/10.1186/s12888-022-03758-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842889/
https://www.ncbi.nlm.nih.gov/pubmed/35164737
http://dx.doi.org/10.1186/s12888-022-03758-w

Ejemplares similares